Drugs & Targets Cleave Biosciences’s CB-5083 receives FDA orphan drug designation July 17, 2015Vol.41 No.28
Drugs & Targets FDA grants orphan drug designation to ImMucin in multiple myeloma July 17, 2015Vol.41 No.28
Drugs & Targets Eli Lilly and Immunocore launch clinical trial collaboration July 17, 2015Vol.41 No.28
Drugs & Targets Proton Partners International Ltd. acquires site for proton beam therapy center in Wales July 02, 2015Vol.41 No.26
Drugs & Targets Mevion Medical Systems delivers proton accelerator to UH Seidman Cancer Center July 02, 2015Vol.41 No.26
